Zydus Lifesciences receives seven observations from USFDA for biologics injectable plant in Ahmedabad

Zydus Life said the US Food and Drug Administration (USFDA) conducted the good manufacturing practices (GMP) surveillance inspection at its Unit 9 facility at Zydus Biotech Park in Changodar, Ahmedabad, from April 27 to May 5, 2026.

Leave a Reply

Your email address will not be published. Required fields are marked *